It is with tremendous sadness that I write about the passing of D.B.S. Jeyaraj. He was a journalist, a chronicler and, for those of us who found our way to the Tamil cause through his words, something ...

Tamil Nadu Chief Minister C. Joseph Vijay on Thursday (May 21, 2026) expanded his Cabinet by inducting 23 more legislators as Ministers, including two from the Congress. Congress party’s S. Rajesh ...

The Tamilaga Vettri Kazhagam (TVK) Cabinet, led by Chief Minister C. Joseph Vijay, was expanded on Thursday (May 21, 2026), with the induction of 23 new members, including two Congress MLAs. The ...

Northwest Multiple Listing Service filed federal counterclaims alleging Compass’ “three-phase marketing program” is a deceptive pocket listing scheme that violates Washington’s Consumer Protection Act ...

Property brokerage Compass on Wednesday dropped its lawsuit against Zillow, ending a legal clash over how home listings can be marketed online. For the past few years, Compass — now the largest real ...

What does the Golden Compass do? If you've just started Act 2 and you're offered the Golden Compass as a helping hand to get you started, here's what you can expect from the item and why you should ...

Compass, the largest residential real estate brokerage in the United States by sales volume, plans to lay off 110 employees in Madison in 2026. The company filed a WARN notice with the New Jersey ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

Learn how to find the current needed to deflect a compass needle in this step-by-step physics tutorial! Explore the principles of magnetic fields, current-carrying wires, and the interaction with a ...

The second of two Phase 3 trials successfully met its primary endpoint in evaluating two fixed doses of COMP360. That's the company's proprietary formulation of psilocybin for TRD. CEO Kabir Nath ...

COMP360 shows rapid symptom improvement in depression study COMP360 may compete with J&J's Spravato if approved Compass plans FDA meeting for rolling submission Feb 17 (Reuters) - Compass Pathways ...